Biom'up announces the approval of HEMOBLAST(TM) Bellows and its laparoscopic applicator in Australia

information fournie par Boursorama •07/10/2019 à 08:00

Biom'up SA, specializing in surgical hemostasis, announces its flagship product, HEMOBLAST Bellows, has been approved for open as well as laparoscopic surgery by the Australian TGA regulatory authority for commercialization in the sizeable and growing Australian market.

Simultaneously, HEMOBLAST Bellows and its laparoscopic applicator have secured reimbursement through the PLAC (Prostheses List Advisory Committee), an independent committee which makes recommendations on the most clinically efficient and effective devices.